The use of dietary supplements RUDVITOL in patients with viral diseases of the anterior segment eye.
IG IVANOV, polyclinic № 5, Kemerovo
One of the most common pathologies in ophthalmology - viral diseases of the eye. They are characterized by undulating course. Their peak often coincides with the peak of SARS. Of viral diseases is not insured nothing. Sick people of any age and sex, duration of illness ranges from an average of 2 weeks to 1 month. As an adjuvant in patients with viral diseases of anterior segment of the eye, we used the biologically active food additives (BAA) RUDVITOL production company ART LIFE.
Main part of the drug - Echinacea purpurea, growing on the territory of North America. In order to enhance immunomodulatory and anti-inflammatory properties in RUDVITOL introduced licorice root extracts, vitamin C, rutin, zinc and selenium.
The drug has a broad spectrum of activity:
- Antiviral (interferon stimulates production of P-2 and interleukin-1);
- For preventing and treating influenza and SARS;
- With immunodeficiency, acute and chronic inflammatory diseases of various sites;
-With anemia, leukopenia;
- In the states after antibiotic therapy, cytostatic and radiation therapy.
Contraindication is the idiosyncrasy of components of the drug.
The aim of the study was to evaluate the influence of the drug on patients with viral diseases of the eye.
Used the following methods:
- Clinical observation of patients;
- Biomicroscopy of anterior segment eye;
- Control blood count.
The study was conducted in outpatients. Attended by two groups: the first (study) was 15 people, including 6 patients with viral conjunctivitis (40%) and 9 (60%) - with viral epithelial keratoconjunctivitis. In the second (control) group - 14 persons, of whom 4 (28.6%) - with viral conjunctivitis, and 10 (71,4%) - with keratoconjunctivitis. Viral conjunctivitis is a mild form of disease that affects mainly conjunctiva of the eyeball. In contrast, in viral keratoconjunctivitis in the process involves the cornea, where there are inflammatory infiltrates, edema, decreased visual acuity. Respectively, and the timing of recovery in this case anymore.
All patients were asked to accept complaints of red eyes, watery eyes. General condition did not suffer. From the blood of any changes were made.
Patients of the study group was appointed BAA RUDVITOL from the first day of the disease. Dose - 3 capsules daily (1 capsule 3 times daily), a course of treatment - 20 days. Patients in both groups received standard antiviral and anti-inflammatory therapy in the installation, and parabulbarno subkonyunktivalngh injections. Patients were examined daily. Portability BAD ART LIFE RUDVITOL was good. While taking the drug and the application of basic treatment improvement occurred in patients with viral conjunctivitis for 6 days in patients of the study group and 9 - in the control group. In patients with viral keratoconjunctivitis - on 12 and 14 day sootvetstvnno.
Full recovery in patients with conjunctivitis first group arrived in 10-12 days, the second group - on day 14. In patients with keratoconjunctivitis - at 20-22 and 25-27 days respectively. Blood picture at the time of recovery in all patients corresponded to the norm.
Clinical trials of biologically active food supplement company RUDVITOL ART LIFE patients with viral diseases of anterior segment eye showed his well-tolerated and no side effects, rapid regression of clinical symptoms, thus reducing time disability patients. While taking RUDVITOL not observed a single case ripple current virus epithelial keratoconjunctivitis.